Category: Tachykinin NK1 Receptors

From March 2013 to July 2016 individuals received intravitreal aflibercept 2?mg in 0.05?mL. were 42 eyes in bevacizumab group, with mean age of 53.2??5.4 years and 27 female individuals of them. The mean BCVA significantly improved from baseline 0.56??0.35 logMAR to 0.35??0.35 logMAR at Month 12 after bevacizumab treatment (p? ?0.001). The mean CFT significantly…